A European technology group had identified an Irish target company as a strategic acquisition. The deal timeline was tight. The acquirer's board had set a firm completion date. What emerged during the process, however, was a series of regulatory conditions that the buyer had not anticipated – conditions that threatened both the timetable and the commercial terms already negotiated.
This case study examines an anonymised M&A transaction in Ireland involving competition clearance obligations, complex closing conditions, and a renegotiated share purchase agreement. The Competition and Consumer Protection Commission (CCPC) reviewed the transaction under Irish merger control rules. Clearance was obtained, but only after the parties restructured key representations and warranties and amended the SPA to reflect revised closing conditions.
This account covers the client profile, the legal strategy adopted, the milestones reached, the complications encountered, and three transferable lessons for businesses pursuing similar cross-border acquisitions in Ireland.
Client profile and the challenge they faced
The client was a mid-sized technology group headquartered on the European continent. It had no prior transactional experience in Ireland. The target was an Irish company operating in a market with a small number of active players. That concentration made competition scrutiny predictable – yet the client had initially underestimated its significance.
The core challenge was dual. First, the transaction was notifiable to the Competition and Consumer Protection Commission (CCPC) – the Irish authority responsible for merger control and consumer protection. Second, the parties had already executed a letter of intent with a closing long-stop date that left insufficient time for a full Phase 1 review, let alone any Phase 2 inquiry.
The client's in-house team had drafted an early version of the share purchase agreement (SPA) without building in adequate regulatory conditions. The closing conditions section did not reflect the Irish merger control timetable. Representations and warranties were based on a standard civil-law template that did not map cleanly onto Irish corporate legislation. This created exposure on both sides of the transaction.
Engaging a lawyer in Ireland with cross-border M&A experience was the first corrective step the client took after the initial review flagged these gaps. Our team was instructed at that point – approximately six weeks before the anticipated signing date.
Legal strategy: structure, rationale, and sequence
The strategic priority was to preserve the commercial deal while building a legally sound structure around it. Three parallel workstreams ran simultaneously.
Workstream one: SPA restructuring. The existing draft SPA required significant revision. The closing conditions were rewritten to make completion expressly conditional on CCPC clearance. Longstop provisions were extended to give the parties a realistic runway if the review extended beyond the standard Phase 1 period. Representations and warranties were re-aligned to Irish corporate legislation standards – covering title, capacity, material contracts, and employment obligations. A specific warranty was introduced addressing the target's regulatory standing under Irish competition law.
Workstream two: merger notification preparation. A thorough due diligence exercise was conducted on the competitive dynamics of the relevant market. The notification to the CCPC was prepared with detailed market share analysis, product substitutability data, and a substantive assessment of competitive effects. The goal was to give the CCPC everything it needed to complete a Phase 1 review within the standard timetable – reducing the risk of a Phase 2 referral.
Workstream three: risk allocation between the parties. The renegotiated SPA introduced a regulatory risk allocation mechanism. A reverse break fee was agreed in the event that the acquirer failed to support the notification process adequately. The seller obtained stronger protections in the event of a Phase 2 referral causing delay beyond the extended longstop. This balanced commercial pressure against legal risk on both sides. For the broader corporate law dimensions of the Irish target structure, the team also reviewed matters covered in our corporate law practice in Ireland.
To explore how legal options for cross-border acquisitions in Ireland can be structured to your specific timeline and risk profile, schedule a consultation at info@ferrazwhitmore.com.
Key milestones and complications encountered
The transaction progressed through four identifiable milestones.
Milestone one: SPA execution. A revised SPA incorporating the restructured closing conditions and updated representations and warranties was signed within three weeks of our instruction. Both parties accepted the extended longstop. The reverse break fee mechanism was agreed without material dispute.
Milestone two: CCPC notification. The merger notification was filed promptly after signing. The CCPC acknowledged receipt and the Phase 1 clock began. The notification included a substantive pre-assessment of competitive effects. This reduced the likelihood of the CCPC requesting significant additional information – a common source of delay in Irish merger reviews.
Milestone three: CCPC information request. This was the principal complication. Despite the thoroughness of the notification, the CCPC issued a formal request for additional information during Phase 1. The request focused on the target's upstream supplier relationships and their potential impact on third-party competitors. This paused the review clock and required the client to produce internal commercial documents on short notice.
The document production exercise required careful coordination. Certain materials contained commercially sensitive pricing data. Redaction decisions had to be made quickly and defensibly. The CCPC's request also raised questions about whether the transaction might require behavioural conditions – a scenario the parties had not fully anticipated. A related cross-border matter involving a comparable transaction structure is examined in our case study on M&A transactions in Portugal, where regulatory conditions posed a similar challenge in a civil law context.
Milestone four: conditional clearance and closing. The CCPC ultimately granted Phase 1 clearance subject to a behavioural condition. The condition required the acquirer to maintain certain supply terms with third parties for a defined period post-closing. This was incorporated into a revised closing conditions schedule. The SPA was amended by supplemental agreement. Closing took place within the extended longstop period.
A full account of the M&A services available for transactions of this type is set out in our M&A practice in Ireland.
Three transferable lessons for cross-border M&A in Ireland
Lesson one: build regulatory conditions into the SPA before signing. Not after. The most significant avoidable risk in this transaction arose from the initial SPA draft. This did not treat CCPC clearance as a genuine closing condition. Renegotiating this after signing – under time pressure and with a commercially motivated seller – was costly in both time and goodwill. In any Irish M&A transaction where turnover thresholds are met, merger control provisions must be embedded in the SPA from the outset. The closing conditions, longstop date, and break fee structure should all reflect the realistic Irish merger review timeline.
Lesson two: due diligence must address competition law exposure, not just financial and legal risk. Standard due diligence templates used in other jurisdictions frequently omit a dedicated competition law workstream. In Ireland, where the CCPC applies a rigorous substantive test, this omission can produce material surprises. A competition-focused due diligence review should assess market concentration, the target's competitive position, and the likelihood of behavioural conditions. Identifying these issues before notification allows the acquirer to model the commercial impact of potential conditions before committing to the deal.
Lesson three: representations and warranties must reflect Irish corporate legislation, not a generic civil law standard. Cross-border acquirers frequently import warranty drafting from their home jurisdiction. Irish corporate legislation and common law interpretation of contractual warranties differ in meaningful ways from civil law equivalents. Warranty coverage for title, capacity, regulatory compliance, and employment matters must be calibrated to the Irish legal context. A misaligned warranty schedule creates disclosure gaps that can become the basis for post-closing disputes – precisely the outcome that a well-negotiated SPA is designed to prevent.
For a tailored strategy on M&A transactions and competition clearance in Ireland, reach out to info@ferrazwhitmore.com.
About Ferraz & Whitmore
Ferraz & Whitmore is an international law firm based in Lisbon, advising business clients across 46 jurisdictions. Our M&A practice covers transaction structuring, regulatory clearance, due diligence, and SPA negotiation across both common law and civil law systems. The firm's attorneys have advised on share purchase agreement matters and competition filings across multiple European jurisdictions, combining Portuguese civil law expertise with English common law tradition. As a law firm in Ireland and across Europe, we work with international acquirers, institutional investors, and in-house legal teams who require cross-border M&A counsel with genuine regulatory depth. Our Lisbon base provides direct access to EU regulatory bodies, while our common law expertise supports deal execution in Irish and English-speaking jurisdictions. To discuss your transaction, contact us at info@ferrazwhitmore.com.
Disclaimer: This publication is provided for informational purposes only and does not constitute legal advice. The information herein should not be relied upon as a substitute for professional legal counsel tailored to your specific circumstances. Ferraz & Whitmore assumes no liability for actions taken or not taken based on the contents of this material. For advice regarding your particular situation, please contact info@ferrazwhitmore.com.